Drug Shortage Report for TEVA-TEMOZOLOMIDE
Report ID | 132279 |
Drug Identification Number | 02441160 |
Brand name | ACT TEMOZOLOMIDE |
Common or Proper name | TEMOZOLOMIDE 5MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 5 |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-20 |
Estimated end date | 2021-06-30 |
Actual end date | 2021-06-02 |
Shortage status | Resolved |
Updated date | 2021-06-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-01-22 | English | Compare |
v2 | 2021-01-22 | French | Compare |
v3 | 2021-02-18 | English | Compare |
v4 | 2021-02-18 | French | Compare |
v5 | 2021-04-29 | English | Compare |
v6 | 2021-04-29 | French | Compare |
v7 | 2021-05-27 | English | Compare |
v8 | 2021-05-27 | French | Compare |
v9 | 2021-06-03 | English | Compare |
v10 | 2021-06-03 | French | Compare |
Showing 1 to 10 of 10